LATEST NEWS

Long-term evaluation of the novel radioenhancer NBTXR3 plus radiotherapy in patients with locally advanced soft tissue sarcoma treated in the phase II/III Act.In.Sarc trial

For inquiries about our technology, collaborations, clinical trials, or other topics, we encourage you to get in touch with our team.